ArticleHGG advances2026
A pseudotime-dependent TWAS framework identifies disease genes along cell developmental paths.
Article in HGG advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
10 authors.
Funding
Abstract
Transcriptome-wide association studies (TWASs) link genes to disease risk by integrating gene expression with genome-wide association study (GWAS) data. The growing availability of single-cell expression data offers the opportunity to dissect these associations at finer cellular resolution and uncover effects masked in bulk TWAS analyses. Existing single-cell TWAS methods often map associations to discrete cell types, potentially overlooking the continuous nature of cellular processes and misidentifying the causal cell stages where genes exert their effects. To address this limitation, we developed the pseudotime-dependent TWAS (pt-TWAS), a framework that models gene expression as a continuous function of pseudotime to capture dynamic gene effects along developmental trajectories. By flexibly modeling and utilizing shared genetic effects across cell stages, this approach achieved higher statistical power than existing single-cell TWAS methods in our extensive simulations. pt-TWAS further enables identification of causal cell stages underlying disease risk by constructing confidence bands for gene effect curves. Applied to a GWAS of B cell acute lymphoblastic leukemia using single-cell data from OneK1K, pt-TWASs replicated known risk genes and pinpointed their relevant cell stages, demonstrating its utility for revealing fine-grained, cell-stage-specific genetic mechanisms. An R package implementing pt-TWASs is available on GitHub.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.